← All diseases Cancer

Prostate cancer (metastatic)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (137)Meta-analysis (28)Treatment guideline (1)Randomized trial (67)Phase 3 study (21)Systematic review (20)Clinical trial (627)Review article (238)Early study (phase 1 or 2) (44)Single patient description (132)Laboratory or animal study (27)Commentary or editorial (29)Retracted publication (3) Studies currently recruiting participants only (49)

Filter

Publications and studies (2075)

• Healthy lifestyle and prostate cancer risk in the Million Veteran Program. (2024/10/15) ♡
• A Cross-sectional Survey of Physicians to Understand Biomarker Testing and Treatment Patterns in Patients with Prostate Cancer in the USA, EU5, Japan, and China. (2024/10/10) ♡
• Genitourinary toxicity after pelvic radiation: Prospective review of complex urological presentations. (2024/10/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Prognostic Nutritional Index (PNI) as Independent Predictor of Poor Survival in Prostate Cancer: A Systematic Review and Meta-Analysis. (2024/10/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. BRCA testing in metastatic castration-resistant prostate cancer: successes and troubles in a real world setting. An Italian Multicentric study. (2024/10/01) ♡
• Quantitative Assessment of Photoneutron-induced Secondary Radiation Dose in Prostate Treatment Using an 18 MV Medical Linear Accelerator: A Monte Carlo Study. (2024/10/01) ♡
• Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. Phytochemical screening, HPLC fingerprinting and in vitro assessment of therapeutic potentials of different apricot cultivars against diabetes, Alzheimer's disease and cancer. (2024/09/28) ♡
• Relationship between oxidative balance score and prostate cancer: a cross-sectional study of NHANES, 1999-2010. (2024/09/16) ♡
• Testing home-based exercise strategies in underserved minority cancer patients undergoing chemotherapy (THRIVE) trial: a study protocol. (2024/09/16) ♡
• Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysis. (2024/09/03) ♡
• Measuring the impact of new risk factors within survival models. (2024/09/03) ♡
• Reactivation of nucleases with peroxidation damages induced by a menadione: ascorbate combination devastates human prostate carcinomas: ultrastructural aspects. (2024/09/02) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronel. (2024/09/01) ♡
• Does the type of the previous biopsy affect the fusion prostate biopsy results? (2024/09/01) ♡
• Sleep and health improvement programme (SHIP) for patients with prostate cancer and caregivers. (2024/08/31) ♡
• Quality of Life Determinants in Patients with Metastatic Prostate Cancer: Insights from a Cross-Sectional Questionnaire-Based Study. (2024/08/26) ♡
• How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden? (2024/08/17) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Is Minimal Change Disease Associated with Prostate Cancer or Is Age Just a Number? (2024/08/13) ♡
• Prognostic factors for non‑metastatic castration‑resistant prostate cancer treated with androgen receptor signaling inhibitors. (2024/08/08) ♡
• Association between Bisphenol A and Prostate-Specific Antigen (PSA) among U.S. Older Males: National Health and Nutrition Examination Survey (NHANES), 2003-2012. (2024/08/06) ♡
• Scientific opinion on the tolerable upper intake level for vitamin E. (2024/08/02) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Heterogeneity of Radiological Progression Patterns and Association with Outcomes in Patients with Metastatic Prostate Cancer. (2024/08/01) ♡
• Development and Validation of a Machine Learning Model for Bone Metastasis in Prostate Cancer: Based on Inflammatory and Nutritional Indicators. (2024/08/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. (2024/08/01) ♡
• Cytotoxicity of Benzofuran-Containing Simplified Viniferin Analogues. (2024/08/01) ♡
• The role of endocrine gland derived vascular growth factor/ Prokineticin-1 in human prostate cells. (2024/07/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Sternal Leiomyosarcoma. (2024/07/26) ♡
• Novel systems biology experimental pipeline reveals matairesinol's antimetastatic potential in prostate cancer: an integrated approach of network pharmacology, bioinformatics, and experimental validation. (2024/07/25) ♡
• A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer. (2024/07/02) ♡
• Splice-switching antisense oligonucleotide controlling tumor suppressor REST is a novel therapeutic medicine for neuroendocrine cancer. (2024/07/02) ♡
• Healthy dietary patterns and risk of prostate cancer in men at high genetic risk. (2024/07/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Enhancing circulatory myokines and extracellular vesicle uptake with targeted exercise in patients with prostate cancer (the MYEX trial): a single-group crossover study. (2024/07/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients. (2024/06/27) ♡
• Mediating Effects of Self-Efficacy and Illness Perceptions on Mental Health in Men with Localized Prostate Cancer: A Secondary Analysis of the Prostate Cancer Patient Empowerment Program (PC-PEP) Randomized Controlled Trial. (2024/06/27) ♡
• Estimating disease burden using national linked electronic health records: a study using an English population-based cohort. (2024/06/19) ♡
• Effect of smoking on prostate cancer: Results from the National Health and Nutrition Examination Survey 2003-2018 and Mendelian randomization analyses. (2024/06/04) ♡
• The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality. (2024/06/01) ♡
• Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer. (2024/06/01) ♡
• Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients. (2024/06/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Nonsurgical Interventions to Prevent Disease Progression in Prostate Cancer Patients on Active Surveillance: A Systematic Review and Meta-analysis. (2024/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic Response to Androgen Deprivation Therapy of Prostate Cancer. (2024/05/24) ♡
• Cost analysis of next-generation imaging in high-risk prostate cancer staging. (2024/05/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Plant-Based Diets and Disease Progression in Men With Prostate Cancer. (2024/05/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial. (2024/04/18) ♡
• Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study. (2024/04/09) ♡
• Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis. (2024/04/03) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A systematic review of cytoreductive prostatectomy outcomes and complications in oligometastatic disease. (2024/04/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401. (2024/04/01) ♡
• Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer. (2024/04/01) ♡
• Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone Metastases: An Analysis of Electronic Health Record Data in the United States From 2014 to 2018. (2024/04/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.